BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26337683)

  • 1. Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.
    Quinlivan A; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Intern Med J; 2015 Nov; 45(11):1134-40. PubMed ID: 26337683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost savings with a novel algorithm for early detection of systemic sclerosis-related pulmonary arterial hypertension: alternative scenario analyses.
    Quinlivan A; Proudman S; Sahhar J; Stevens W; Nikpour M;
    Intern Med J; 2019 Jun; 49(6):781-785. PubMed ID: 31185523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
    Hao Y; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker J; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2015 Jan; 17(1):7. PubMed ID: 25596924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
    Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.
    Thakkar V; Stevens WM; Moore OA; Nikpour M
    Intern Med J; 2013 Jul; 43(7):751-60. PubMed ID: 23611651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Comparison of DETECT algorithm to decisions of a multidisciplinary team, in a competence centre].
    Coirier V; Lescoat A; Fournet M; Cazalets C; Coiffier G; Jouneau S; Chabanne C; Jégo P
    Rev Med Interne; 2017 Aug; 38(8):502-507. PubMed ID: 28545856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.
    Vandecasteele E; Drieghe B; Melsens K; Thevissen K; De Pauw M; Deschepper E; Decuman S; Bonroy C; Piette Y; De Keyser F; Brusselle G; Smith V
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28495691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
    Hachulla E; Gressin V; Guillevin L; Carpentier P; Diot E; Sibilia J; Kahan A; Cabane J; Francès C; Launay D; Mouthon L; Allanore Y; Tiev KP; Clerson P; de Groote P; Humbert M
    Arthritis Rheum; 2005 Dec; 52(12):3792-800. PubMed ID: 16320330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
    Ghosh SK; Corkill MM; Hart HH; Ng KP
    N Z Med J; 2014 Aug; 127(1400):30-8. PubMed ID: 25145365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice?
    Pauling JD; McHugh NJ
    Clin Rheumatol; 2012 Feb; 31(2):357-61. PubMed ID: 21912881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
    Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
    Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort.
    Hoffmann-Vold AM; Fretheim H; Midtvedt Ø; Kilian K; Angelshaug M; Chaudhary A; Gunnarsson R; Brunborg C; Garen T; Andreassen AK; Gude E; Molberg Ø
    Rheumatology (Oxford); 2018 Mar; 57(3):480-487. PubMed ID: 29237073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
    Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
    Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.
    Morrisroe K; Stevens W; Sahhar J; Rabusa C; Nikpour M; Proudman S;
    Arthritis Res Ther; 2017 Mar; 19(1):42. PubMed ID: 28270192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
    Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
    Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.